NEJM Journal Watch - General Medicine

Findings from an industry-sponsored, phase 2 trial of abelacimab suggest reduced bleeding compared with rivaroxaban.

Results from a multicenter observational study are interesting but don't resolve the controversy surrounding this diagnosis.

This study adds to the body of evidence favoring NIV in obese patients at risk for postextubation respiratory failure.

Diabetic patients with eGFRs <30 mL/minute/1.73 m2 who continued metformin had lower mortality at 3 years.

Several observational studies suggest this link is real.

Dr. Paul Sax reacts to the first measles death in the United States since 2015 in HIV and ID Observations.

Aztreonam–avibactam is active against metallo-β-lactamase–producing Enterobacterales and Stenotrophomonas maltophilia.

An observational study suggests inpatient continuation is associated with lower risk for hypoglycemia and death after discharge.

This update discusses new risk stratification criteria, refinement of cardiovascular imaging, and updated medical management.

A small randomized study failed to show a benefit of TAVR in this population.